These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3649223)

  • 21. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Corpus cavernosum autoinjection therapy in erectile dysfunction?].
    Jung A; Schill WB
    Med Monatsschr Pharm; 1994 Sep; 17(9):277-8. PubMed ID: 7968780
    [No Abstract]   [Full Text] [Related]  

  • 23. A positive urine opiate screen following intracavernosal papaverine injection.
    Pierpaoli SM; Mulhall JP
    J Urol; 1998 Apr; 159(4):1299. PubMed ID: 9507861
    [No Abstract]   [Full Text] [Related]  

  • 24. [Trial of intracavernous papaverine in the treatment of impotence. Therapeutic prospects].
    Virag R; Virag H
    J Mal Vasc; 1983; 8(4):293-5. PubMed ID: 6663198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical prosthesis.
    Zenico T; Zoli M; Maltoni G
    Acta Urol Belg; 1989; 57(1):223-6. PubMed ID: 2718845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
    Viswaroop B; B A; Gopalakrishnan G
    Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracavernous injection of alprostadil for erectile dysfunction.
    Med Lett Drugs Ther; 1995 Sep; 37(958):83-4. PubMed ID: 7674992
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Our experience with pharmacological erection treatment of erectile dysfunction.
    Hattat H; Ozkara H; Akkus E; Alici B
    J Androl; 1994; 15 Suppl():47S-49S. PubMed ID: 7721677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
    El-Sakka AI
    Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reasons for high drop-out rate with self-injection therapy for impotence.
    Weiss JN; Badlani GH; Ravalli R; Brettschneider N
    Int J Impot Res; 1994 Sep; 6(3):171-4. PubMed ID: 7735362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic erection program: an alternative solution for the man with erectile dysfunction.
    Grégoire I
    Urol Nurs; 1995 Mar; 15(1):10-3. PubMed ID: 7792617
    [No Abstract]   [Full Text] [Related]  

  • 36. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term results of the treatment with intracavernous injection of vasoactive drugs].
    Rodríguez Vela L; Gonzalvo Ibarra A; Gil Martínez P; Benejan Gual J; Cuesta Presedo JM; Ríoja Sanz LA
    Arch Esp Urol; 1996 Apr; 49(3):257-69. PubMed ID: 8702347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
    Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
    Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.